These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6546626)

  • 1. Chemotherapy of hormone-refractory carcinoma of prostate with 5-fluorouracil, adriamycin, and mitomycin C.
    Babaian RJ; Hsu SD
    Urology; 1984 Mar; 23(3):272-5. PubMed ID: 6546626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate].
    Yoshimoto J; Ochi J; Tanahashi T; Nanba K; Saegusa M; Hara M; Akagi T; Obama T; Tsushima T; Ozaki Y
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):434-9. PubMed ID: 2434029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin, mitomycin C and 5-fluorouracil in the treatment of hormone refractory adenocarcinoma of the prostate: a Southwest Oncology Group study.
    Blumenstein B; Crawford ED; Saiers JH; Stephens RL; Rivkin SE; Coltman CA
    J Urol; 1993 Aug; 150(2 Pt 1):411-3. PubMed ID: 8326565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer.
    Logothetis CJ; Samuels ML; von Eschenbach AC; Trindade A; Ogden S; Grant C; Johnson DE
    J Clin Oncol; 1983 Jun; 1(6):368-79. PubMed ID: 6422006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hormone-resistant metastatic carcinoma of the prostate with 5-FU, doxorubicin, and mitomycin (FAM'): a preliminary report.
    Kasimis BS; Moran EM; Miller JB; Forbes KA; Kaneshiro CA; Poblet MT; Williams JL
    Cancer Treat Rep; 1983 Oct; 67(10):937-9. PubMed ID: 6688755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C.
    Cunningham D; Soukop M; McArdle CS; Carter DC; Smyth JF; Allan SG; Kaye SB; Sangster G; Calman KC; Hutcheon AW
    Br J Surg; 1984 Sep; 71(9):673-6. PubMed ID: 6548166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIFA III (mitomycin-C, 5-fluorouracil, and adriamycin) chemotherapy for advanced adenocarcinoma of the pancreas.
    Sternberg CN; Magill GB; Sordillo PP; Cheng EW
    Am J Clin Oncol; 1984 Oct; 7(5):529-33. PubMed ID: 6391145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide versus 5-fluorouracil, doxorubicin, and mitomycin C (FAM') in the treatment of hormone-resistant metastatic carcinoma of the prostate: a preliminary report of a randomized trial.
    Kasimis BS; Miller JB; Kaneshiro CA; Forbes KA; Moran EM; Metter GE
    J Clin Oncol; 1985 Mar; 3(3):385-92. PubMed ID: 3838343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin, mitomycin, and 5-FU (DMF) in the treatment of hormone-resistant stage D prostate cancer: a preliminary report.
    Logothetis CJ; von Eschenbach AC; Samuels ML; Trindade A; Johnson DE
    Cancer Treat Rep; 1982 Jan; 66(1):57-63. PubMed ID: 7053267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung.
    Shepherd FA; Evans WK; Burkes R; Paul K; DeBoer G
    Am J Clin Oncol; 1986 Oct; 9(5):392-6. PubMed ID: 3776901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas.
    Sulkes A; Uziely B; Isacson R; Brufman G; Biran S
    Isr J Med Sci; 1988; 24(9-10):604-10. PubMed ID: 3204009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM).
    Haim N; Epelbaum R; Cohen Y; Robinson E
    Cancer; 1984 Nov; 54(9):1999-2002. PubMed ID: 6548173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary.
    Goldberg RM; Smith FP; Ueno W; Ahlgren JD; Schein PS
    J Clin Oncol; 1986 Mar; 4(3):395-9. PubMed ID: 3754004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma.
    Gibson MK; Holcroft CA; Kvols LK; Haller D
    Oncologist; 2005 Feb; 10(2):132-7. PubMed ID: 15709215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of metastasizing prostatic carcinoma with DMF. Presentation of a prospective study].
    Burk K; Gropp C; Rodeck G
    Urologe A; 1983 Sep; 22 Suppl():347-9. PubMed ID: 6415885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in adenocarcinoma of the parotid gland].
    Inoue K; Horikoshi N; Mukaiyama T; Ogawa M; Kuraishi Y
    Gan No Rinsho; 1989 Mar; 35(4):481-5. PubMed ID: 2654442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of epirubicin, mitomycin C, and 5-fluorouracil in hormone-refractory prostatic carcinoma.
    Recchia F; Sica G; De Filippis S; Rosselli M; Pompili PL; Rea S
    Am J Clin Oncol; 2001 Jun; 24(3):232-6. PubMed ID: 11404491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined 5-fluorouracil, adriamycin and mitomycin C in the management of adenocarcinoma metastasizing to the liver from an unknown primary site.
    al-Idrissi HY
    J Int Med Res; 1990; 18(5):425-9. PubMed ID: 2124191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of intrahepatic bile duct cancer responding to 5-fluorouracil, adriamycin and mitomycin C chemotherapy].
    Uchiyama K; Takada T; Yasuda H; Hasegawa H; Tsuchiya S; Misu Y; Saitoh Y; Shikata J; Kozakai M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1987-90. PubMed ID: 3132897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experiences with polychemotherapy MAF (mitomycin C, adriablastine, 5-fluorouracil) in progressing metastasized prostate cancer].
    Burk K; Gropp C; de Riese W; Löbenau S
    Helv Chir Acta; 1985 Sep; 52(3-4):601-3. PubMed ID: 3934112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.